Impact of Aortic Atherosclerosis Burden on Outcomes of Surgical Aortic Valve Replacement
- PMID: 31400333
- PMCID: PMC6939455
- DOI: 10.1016/j.athoracsur.2019.06.037
Impact of Aortic Atherosclerosis Burden on Outcomes of Surgical Aortic Valve Replacement
Abstract
Background: Epiaortic ultrasound detects and localizes ascending aortic atherosclerosis. In this analysis we investigated the association between epiaortic ultrasound-based atheroma grade during surgical aortic valve replacement (SAVR) and perioperative adverse outcomes.
Methods: SAVR patients in a randomized trial of 2 embolic protection devices underwent a protocol-defined 5-view epiaortic ultrasound read at a core laboratory. Aortic atherosclerosis was quantified with the Katz atheroma grade, and patients were categorized as mild (grade I-II) or moderate/severe (grade III-V). Multivariable logistic regression was used to estimate associations between atheroma grade and adverse outcomes, including death, clinically apparent stroke, cerebral infarction on diffusion-weighted magnetic resonance imaging, delirium, and acute kidney injury (AKI) by 7 and 30 days.
Results: Precannulation epiaortic ultrasound data were available for 326 of 383 randomized patients (85.1%). Of these, 106 (32.5%) had moderate/severe Katz atheroma grade at any segment of the ascending aorta. Although differences in the composite of death, stroke, or cerebral infarction on diffusion-weighted magnetic resonance imaging by 7 days were not statistically significant, moderate/severe atheroma grade was associated with a greater risk of AKI by 7 days (adjusted odds ratio, 2.63; 95% confidence interval, 1.24-5.58; P = .01). At 30 days, patients with moderate/severe atheroma grade had a greater risk of death, stroke, or AKI (adjusted odds ratio, 1.97; 95% confidence interval, 1.04-3.71; P = .04).
Conclusions: Moderate/severe aortic atherosclerosis was associated with an increased risk of adverse events after SAVR. Epiaortic ultrasound may serve as a useful adjunct for identifying patients who may benefit from strategies to reduce atheroembolic complications during SAVR.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Invited Commentary.Ann Thorac Surg. 2020 Feb;109(2):471-472. doi: 10.1016/j.athoracsur.2019.07.091. Epub 2019 Sep 14. Ann Thorac Surg. 2020. PMID: 31526780 No abstract available.
-
Avoiding Manipulation of the Aorta Reduces the Adverse Events: Of Course, but Which Manipulations?Ann Thorac Surg. 2020 Jun;109(6):1952-1953. doi: 10.1016/j.athoracsur.2019.09.092. Epub 2019 Nov 22. Ann Thorac Surg. 2020. PMID: 31765614 No abstract available.
References
-
- Thiagarajan K, Jeevanantham V, Van Ham R, et al. Perioperative Stroke and Mortality After Surgical Aortic Valve Replacement: A Meta-Analysis. Neurologist. 2017;22(6):227–233. - PubMed
-
- Udesh R, Mehta A, Gleason T, Thirumala PD. Carotid artery disease and perioperative stroke risk after surgical aortic valve replacement: A nationwide inpatient sample analysis. J Clin Neurosci. 2017;42:91–96. - PubMed
-
- Agarwal S, Garg A, Parashar A, et al. In-hospital mortality and stroke after surgical aortic valve replacement: A nationwide perspective. J Thorac Cardiovasc Surg. 2015;150(3):571–8.e8. - PubMed
-
- Idrees JJ, Schiltz NK, Johnston DR, et al. Trends, Predictors, and Outcomes of Stroke After Surgical Aortic Valve Replacement in the United States. Ann Thorac Surg. 2016;101(3):927–35. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
